BOSTON (GenomeWeb News) – A targeted gene panel developed by University of Washington researchers found that some women, who had a family history of breast and ovarian cancer, and who had received negative test results from Myriad Genetics' BRACAnalysis test, in fact, had BRCA1 and BRCA2 mutations that BRACAnalysis did not pick up.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.